ClinVar Miner

Submissions for variant NM_000363.5(TNNI3):c.246G>T (p.Pro82=)

gnomAD frequency: 0.00007  dbSNP: rs397516343
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000036278 SCV000059930 likely benign not specified 2012-06-04 criteria provided, single submitter clinical testing Pro82Pro in exon 5 of TNNI3: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. Pro82Pro in exon 5 of TNNI3 (allele frequency = n/a)
GeneDx RCV000036278 SCV000520165 likely benign not specified 2017-03-30 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000769530 SCV000900925 likely benign Cardiomyopathy 2016-12-29 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000769530 SCV001351787 likely benign Cardiomyopathy 2019-04-26 criteria provided, single submitter clinical testing
Invitae RCV002054584 SCV002475805 likely benign Hypertrophic cardiomyopathy 2023-12-02 criteria provided, single submitter clinical testing
Ambry Genetics RCV002444470 SCV002733922 likely benign Cardiovascular phenotype 2022-08-29 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.